New research suggests that ursodeoxycholic acid, a cheap liver drug, could reduce SARS-CoV-2 transmission in hospitals by 17%. Using computer simulations, scientists modelled how the drug lowers ACE2 ...

Principles of Medicine in Africa - June 2025

YouTube video by MRC - UofGlasgow Centre for Virus Research

Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) is a deadly tick-borne virus and a growing global health threat. In this study, Petit et al. used a multi-omics approach on SFTSV-infected tick cells to study its impact and reveal host antiviral responses and key restriction factors.

The study, published in Nature Communications, provides the most detailed picture yet of how cells from the tick species Rhipicephalus microplus respond to infection with severe fever with thrombocytopenia syndrome virus (SFTSV).SFTSV can cause high fever, internal bleeding and death in humans and currently has no licensed treatment or vaccine.

Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) is a deadly tick-borne virus and a growing global health threat. In this study, Petit et al. used a multi-omics approach on SFTSV-infected tick cells to study its impact and reveal host antiviral responses and key restriction factors.

The study, published in Nature Communications, provides the most detailed picture yet of how cells from the tick species Rhipicephalus microplus respond to infection with severe fever with thrombocytopenia syndrome virus (SFTSV).SFTSV can cause high fever, internal bleeding and death in humans and currently has no licensed treatment or vaccine.